Vilya

About:

Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease.

Top Investors: Menlo Ventures, NVentures, Madrona, ARCH Venture Partners, Lifeforce Capital

Description:

Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease. The company aims to create new medicines to leverage computing to make high throughput screening obsolete and cure diseases.

Total Funding Amount:

$71M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2022-01-01

Contact Email:

info(AT)vilyatx.com

Founders:

Sabah Oney

Number of Employees:

11-50

Last Funding Date:

2024-06-04

IPO Status:

Private

Industries: